APA (7th ed.) Citation

BB, S., C, M., JR, C., C, R., H, M., SA, Q., . . . T, P. (2024). Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. The Journal of investigative dermatology, 144(7), 1579. https://doi.org/10.1016/j.jid.2023.12.010

Chicago Style (17th ed.) Citation

BB, Shih, et al. "Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma." The Journal of Investigative Dermatology 144, no. 7 (2024): 1579. https://doi.org/10.1016/j.jid.2023.12.010.

MLA (9th ed.) Citation

BB, Shih, et al. "Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma." The Journal of Investigative Dermatology, vol. 144, no. 7, 2024, p. 1579, https://doi.org/10.1016/j.jid.2023.12.010.